CIK: 1270083 - Address: 3625 132Nd Avenue Se, Bellevue, WA 98006
9 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

S%ret1143321-3203613
S%wins0001000017

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y

2/6/07 11:53
2/2/07
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADM.d531.05550999%50D-170182128261650-4-2-34-26
8/29/06 17:13
8/24/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADS.m-1844.854-38-1000D30-32-19-24-10-6174123-82231
8/28/06 18:45
8/23/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADS.m-594.884-12-2438D26-35-22-28-13-113-12420-11938
8/28/06 18:45
6/30/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADS.m-1224.734-26-1000D26-35-22-28-13-113-12420-11938
8/28/06 18:44
6/28/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADS.m-1974.814-41-6126D26-35-22-28-13-113-12420-11938
8/28/06 18:44
8/8/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADM.a531.05450999%50D26-35-22-28-13-113-12420-11938
8/28/06 18:44
5/23/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADM.a370.5500467New67D26-35-22-28-13-113-12420-11938
8/10/06 12:33
8/8/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADM.d531.05350New50D25-29-27-38-28-13-15-15-211213367
5/24/06 14:33
5/23/06
DDDScolr Pharma, Inc.DEHealthDiagnIn Vitro & In Vivo DiagnosticFassihi RezaWADM.d370.55005672001000-4-7-27-23-3

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact